How cell structure affects programmed cell death
Cytoskeletal compartmentalization of apoptotic signaling
This study is looking at how certain proteins help cells decide when to die, especially when they’re damaged, which could lead to new ways to treat diseases by better understanding this process.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-10944665 on NIH RePORTER |
What this research studies
This research investigates the role of the actin cytoskeleton in regulating programmed cell death, particularly in response to DNA damage. The team will explore how specific proteins, known as nucleation factors, influence the formation of actin filaments and their interaction with apoptotic signaling pathways. By understanding these mechanisms, the research aims to uncover how cells manage apoptosis and protect themselves from damage. This could lead to insights into how to manipulate these processes for therapeutic purposes.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to apoptosis dysregulation, such as certain cancers or neurodegenerative diseases.
Not a fit: Patients with conditions unrelated to apoptosis or those who are not experiencing issues with programmed cell death may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing or inhibiting programmed cell death, which is crucial in cancer treatment and other diseases.
How similar studies have performed: While the specific approach of this research is novel, previous studies have shown that understanding cytoskeletal dynamics can significantly impact our knowledge of apoptosis.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Campellone, Kenneth G — University of Connecticut Storrs
- Study coordinator: Campellone, Kenneth G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.